Literature DB >> 6244499

Herpes simplex virus depresses antibody production by affecting T-cell function.

B K Pelton, I B Duncan, A M Denman.   

Abstract

Many viruses enter lympho-reticular cells during pathogenesis and thereby induce immunosuppression, which is of practical importance in that it may be related to overall virulence. Immunosuppression may result from a selective infection, as viruses often show an affinity for different lymphocyte subpopulations: Epstein-Barr virus, for example, infects only a small percentage of B cells. We reported previously that herpes simplex virus (HSV) type 1 suppressed the induction of an antibody response to diphtheria toxoid in cultures of human tonsil cells, and that this seemed to result from the infection of a small percentage of T lymphocytes. However, as fully infectious virus was used in these experiments, it had probably spread from cell to cell in the course of the culture, so complicating the interpretation of the results. Accordingly, we have now reinvestigated the mechanism of immunosuppression using temperature-sensitivity (ts) mutants which fail to complete their growth cycle in the conditions selected for antibody synthesis. In this study, mutants tsB, tsD and tsF, derived from HSV type 1 strain 17, and ts 9, derived from HSV type 2 HG 52, were used. The results suggest that the immunosuppression is due to the selective infection by the viruses of helper T cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6244499     DOI: 10.1038/284176a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  11 in total

Review 1.  Herpes simplex virus and the rheumatic diseases.

Authors:  A M Denman; B K Pelton; W Hylton; R G Palmer; R Topper
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

2.  The in situ cellular immune response in acute herpes simplex encephalitis.

Authors:  R A Sobel; A B Collins; R B Colvin; A K Bhan
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

3.  Herpes simplex virus infection of human T-cell subpopulations.

Authors:  S M Hammer; W P Carney; V R Iacoviello; B R Lowe; M S Hirsch
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

4.  Neutralising antibody in mice with primary and recurrent herpes simplex virus infection.

Authors:  J M Darville; W A Blyth
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

5.  Selective immunosuppressive effects of measles virus infection.

Authors:  B K Pelton; W Hylton; A M Denman
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

6.  Effects of immunosuppression on herpes simplex virus growth in lymphocytes of patients with connective tissue diseases.

Authors:  P Hollingworth; W Hylton; B K Pelton; A M Denman
Journal:  Ann Rheum Dis       Date:  1983-06       Impact factor: 19.103

7.  Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.

Authors: 
Journal:  Ann Rheum Dis       Date:  1982       Impact factor: 19.103

8.  Infection and inhibition of human cytotoxic T lymphocytes by herpes simplex virus.

Authors:  C M Posavad; J J Newton; K L Rosenthal
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Cell-mediated immunity against herpes simplex virus envelope, capsid, excreted, and crude antigens.

Authors:  K O Kalimo; I A Joronen; V K Havu
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  Expression of immunity to intravaginal herpes simplex virus type 2 infection in the genital tract and associated lymph nodes.

Authors:  M R McDermott; P L Brais; G C PLoettsche; M J Evelegh; C H Goldsmith
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.